MGMT METHYLATION IS A PROGNOSTIC BIOMARKER IN ELDERLY PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

by Gerstner, E R., Yip, S, Wang, D L., Louis, D N., Iafrate, A J., Batchelor, T T.
Published 2009

Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma

by Prah, M.A., Stufflebeam, S.M., Paulson, E.S., Kalpathy-Cramer, J., Gerstner, E.R., Batchelor, T.T., Barboriak, D.P., Rosen, B.R., Schmainda, K.M.
Published in AJNR Am J Neuroradiol (2015)

OS6.1 Glioma anatomic location and clinical phenotype relate to regional healthy brain network signature

by Numan, T, Derks, J, de Witt Hamer, P C, Gerstner, E R, Stufflebeam, S M, Alexander, B, van Dijk, K R A, Cagney, D N, Reijneveld, J C, Douw, L
Published in Neuro Oncol (2018)